'Female Viagra' OTC: What Exists (and Doesn't)
SaveNo over-the-counter 'female Viagra' exists: no OTC pill is FDA-approved to boost female desire, and low desire is rarely a blood-flow problem like erections [1]. The approved medicines, flibanserin and bremelanotide, are prescription-only, and gas-station 'enhancement' pills can hide unlisted drugs. Distressing low desire affects about 1 in 10 women and deserves an individual evaluation.
Last updated: July 2026
Is there an over-the-counter 'female Viagra'?
No over-the-counter pill is approved as a 'female Viagra,' and the phrase itself is misleading. Sildenafil, sold as Viagra, increases blood flow for erections, while female sexual concerns are more often about desire, arousal, mood, pain, or hormones, so a blood-flow pill does not translate 1Ref 1American College of Obstetricians and Gynecologists (2019).Female Sexual Dysfunction: ACOG Practice Bulletin, Number 213.ACOG Practice Bulletin on female sexual dysfunction: low desire is common, multifactorial, and evaluated individually; distressing low desire affects about 1 in 10 women, roughly 4 in 10 report a sexual concern, and flibanserin and bremelanotide are the FDA-approved prescription options while no OTC supplement has established efficacy.. The two medicines the FDA has approved for low sexual desire, flibanserin and bremelanotide, are prescription-only and act on brain chemistry, not plumbing. According to the American College of Obstetricians and Gynecologists, distressing low desire affects about 1 in 10 women, but it is evaluated and treated individually, not with a one-size pill 1Ref 1American College of Obstetricians and Gynecologists (2019).Female Sexual Dysfunction: ACOG Practice Bulletin, Number 213.ACOG Practice Bulletin on female sexual dysfunction: low desire is common, multifactorial, and evaluated individually; distressing low desire affects about 1 in 10 women, roughly 4 in 10 report a sexual concern, and flibanserin and bremelanotide are the FDA-approved prescription options while no OTC supplement has established efficacy.. Anything sold as an OTC 'female Viagra' is marketing.
What prescription options actually exist?
A few real prescription treatments exist, and each has clear limits. Flibanserin is a daily pill for premenopausal women with low desire; in trials over about 24 weeks it produced a modest increase in satisfying sexual events and can cause drowsiness and low blood pressure, especially with alcohol 1Ref 1American College of Obstetricians and Gynecologists (2019).Female Sexual Dysfunction: ACOG Practice Bulletin, Number 213.ACOG Practice Bulletin on female sexual dysfunction: low desire is common, multifactorial, and evaluated individually; distressing low desire affects about 1 in 10 women, roughly 4 in 10 report a sexual concern, and flibanserin and bremelanotide are the FDA-approved prescription options while no OTC supplement has established efficacy.. Bremelanotide is an on-demand injection used before sex. For postmenopausal women, an international consensus statement endorsed by The Endocrine Society supports carefully monitored testosterone, which added roughly one satisfying sexual event every 28 days over placebo 2Ref 2Davis SR, et al. (International consensus, endorsed by The Endocrine Society and International Menopause Society) (2019).Global Consensus Position Statement on the Use of Testosterone Therapy for Women.International consensus that carefully monitored testosterone can modestly improve satisfying sexual events in postmenopausal women with low desire (about one additional satisfying sexual event per 28 days versus placebo); it is off-label, prescription-only, and clinician-supervised, not an over-the-counter product.. Hormone therapy can also improve lubrication and comfort when dryness is part of the picture 3Ref 3Nastri CO, Lara LA, Ferriani RA, et al. (2013).Hormone therapy for sexual function in perimenopausal and postmenopausal women.Cochrane review finding hormone therapy modestly improves sexual function and lubrication in peri- and postmenopausal women over roughly 12 weeks; basis for the lifecycle framing that desire, arousal, and natural lubrication shift as estrogen falls.. All of these require a clinician.
Why are gas-station and online enhancement pills risky?
Pills sold at gas stations, sex shops, or through pop-up websites are the riskiest option of all. Because they sidestep regulation, these 'enhancement' products have repeatedly been found to contain hidden prescription drugs, unlisted stimulants, or contaminants that can dangerously interact with heart, blood-pressure, or nitrate medicines. A dramatic health claim, a proprietary blend, or a 'clinically proven' banner with no named study are all warning signs. Undisclosed ingredients are especially hazardous for anyone with cardiovascular conditions. What looks like a cheap, discreet shortcut can carry the very risks that a prescription's monitoring is designed to prevent, without any of the oversight.
What else shapes low desire?
Desire is rarely about one missing pill. Sleep, stress, relationship dynamics, mood, pain with sex, vaginal dryness, thyroid and iron levels, and other medications all influence it, and some antidepressants notably blunt desire, an effect worth exploring as antidepressant side effects rather than chasing a pill 1Ref 1American College of Obstetricians and Gynecologists (2019).Female Sexual Dysfunction: ACOG Practice Bulletin, Number 213.ACOG Practice Bulletin on female sexual dysfunction: low desire is common, multifactorial, and evaluated individually; distressing low desire affects about 1 in 10 women, roughly 4 in 10 report a sexual concern, and flibanserin and bremelanotide are the FDA-approved prescription options while no OTC supplement has established efficacy.. Desire also shifts across life stages, often dipping in the postpartum months and again across the perimenopausal transition as estrogen falls 3Ref 3Nastri CO, Lara LA, Ferriani RA, et al. (2013).Hormone therapy for sexual function in perimenopausal and postmenopausal women.Cochrane review finding hormone therapy modestly improves sexual function and lubrication in peri- and postmenopausal women over roughly 12 weeks; basis for the lifecycle framing that desire, arousal, and natural lubrication shift as estrogen falls.. When strain in a relationship is the driver, low sex drive has causes worth naming directly. A clinician can sort treatable contributors from normal variation.
When low desire is worth a prescription conversation
Low desire that persists and distresses you is worth an honest conversation with a clinician, not a gamble on a drugstore or gas-station pill. A primary care clinician or gynecologist can check for treatable causes, review the two FDA-approved prescription options and off-label testosterone, and weigh the real benefits and side effects for your situation 1Ref 1American College of Obstetricians and Gynecologists (2019).Female Sexual Dysfunction: ACOG Practice Bulletin, Number 213.ACOG Practice Bulletin on female sexual dysfunction: low desire is common, multifactorial, and evaluated individually; distressing low desire affects about 1 in 10 women, roughly 4 in 10 report a sexual concern, and flibanserin and bremelanotide are the FDA-approved prescription options while no OTC supplement has established efficacy.2Ref 2Davis SR, et al. (International consensus, endorsed by The Endocrine Society and International Menopause Society) (2019).Global Consensus Position Statement on the Use of Testosterone Therapy for Women.International consensus that carefully monitored testosterone can modestly improve satisfying sexual events in postmenopausal women with low desire (about one additional satisfying sexual event per 28 days versus placebo); it is off-label, prescription-only, and clinician-supervised, not an over-the-counter product.. That individualized judgment is exactly what an over-the-counter 'female Viagra' cannot offer. Gale can help you prepare questions for that visit.
Common questions
Related
Sexual health
Addyi (Flibanserin): How Well Does It Work?Sexual health
Vyleesi (Bremelanotide): An On-Demand OptionSexual health
Libido Supplements: What's Actually in Them
Say it back
How would you explain this to someone you love?
Two or three sentences, just as you’d say it. Gale reflects back what you focused on — a mirror, not a quiz.
When low desire is worth a clinical visit
- —Low desire that persists and distresses you or strains a relationship is a reason to seek clinician evaluation
- —Any reaction after taking an unregulated 'enhancement' pill, such as chest symptoms, fainting, or a severe headache, is a reason to seek urgent medical care right away
- —New low desire after starting a medication is a reason to review it with the prescriber
- —Pain during sex or new dryness alongside low desire is a reason to see a gynecologist
This article is general health education, not medical advice. Which treatment, if any, fits your situation is best decided with a primary care clinician or gynecologist who knows your history and medications.
References
- 1.American College of Obstetricians and Gynecologists (2019). Female Sexual Dysfunction: ACOG Practice Bulletin, Number 213. Obstetrics & Gynecology. doi:10.1097/AOG.0000000000003324 ✓ACOG Practice Bulletin on female sexual dysfunction: low desire is common, multifactorial, and evaluated individually; distressing low desire affects about 1 in 10 women, roughly 4 in 10 report a sexual concern, and flibanserin and bremelanotide are the FDA-approved prescription options while no OTC supplement has established efficacy.
- 2.Davis SR, et al. (International consensus, endorsed by The Endocrine Society and International Menopause Society) (2019). Global Consensus Position Statement on the Use of Testosterone Therapy for Women. Journal of Clinical Endocrinology & Metabolism. doi:10.1210/jc.2019-01603 ✓International consensus that carefully monitored testosterone can modestly improve satisfying sexual events in postmenopausal women with low desire (about one additional satisfying sexual event per 28 days versus placebo); it is off-label, prescription-only, and clinician-supervised, not an over-the-counter product.
- 3.Nastri CO, Lara LA, Ferriani RA, et al. (2013). Hormone therapy for sexual function in perimenopausal and postmenopausal women. Cochrane Database of Systematic Reviews. doi:10.1002/14651858.CD009672.pub2 ✓Cochrane review finding hormone therapy modestly improves sexual function and lubrication in peri- and postmenopausal women over roughly 12 weeks; basis for the lifecycle framing that desire, arousal, and natural lubrication shift as estrogen falls.
3 sources, numbered by first appearance. General health information, not medical advice. AI-assisted editorial content — every citation independently verified. Editorial policy